Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

Researchers determined the utility of a novel and commercially available immunoassay for plasma phosphorylated tau 217 to detect Alzheimer's Disease pathology and evaluate reference ranges for abnormal amyloid β and longitudinal change across three selected cohorts.

24 Jan 2024

New technique helps track the brain's "off switches"

For decades, scientists have studied the intricate activity patterns in human and animal brains by observing when different groups of brain cells turn on.

23 Jan 2024

What’s indoor air quality like in long-term care facilities during wildfires? Worse than you’d think.

Every year, wildfires across the western U.S. and Canada send plumes of smoke into the sky. When that smoke blows into southwestern Idaho’s Treasure Valley, it blankets Boise-area residents in dirty air.

23 Jan 2024

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Diet modification and alterations in the intestinal microbial population could impact the disease course of Alzheimer’s and Parkinson’s diseases.

23 Jan 2024

Posterior cortical atrophy predicts Alzheimer's, study finds

A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of Alzheimer's disease.

22 Jan 2024

NHS Health Check linked to lower disease rates and mortality, study shows

Attending an NHS Health Check appointment -; a preventative screening programme offered for free in the UK -; is associated with both a decreased risk of dying and a decreased risk of several diseases, including dementia and liver cirrhosis.

22 Jan 2024

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Researchers performed a meta-analysis of randomized trial studies that compared the use of amyloid-reducing monoclonal antibodies (MABs) in patients with Alzheimer's dementia at a dose consistent with that used in Phase 3 or FDA approval trials with the use of a placebo.

22 Jan 2024

Thinning brain tissue predicts dementia up to a decade before symptoms

A ribbon of brain tissue called cortical gray matter grows thinner in people who go on to develop dementia, and this appears to be an accurate biomarker of the disease five to 10 years before symptoms appear, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported.

22 Jan 2024

New study examines trends in liquid laundry detergent packet exposures among young children

A new study conducted by researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children's Hospital and the Central Ohio Poison Center investigated trends in calls to poison centers across the country for exposures to liquid laundry detergent packets.

22 Jan 2024

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

For some patients whose cancer has spread to their bones, the ensuing treatment can be more physically damaging than the original disease, leading to increased bone loss and fracture.

22 Jan 2024

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

Researchers explored how Death Induced by Survival gene Elimination through the analysis of RNA-induced silencing complex-bound short RNAs in Alzheimer's disease models influences neuronal survival and correlates with neurotoxicity in AD.

22 Jan 2024

Unveiling the cellular mechanisms of engram consolidation and memory refinement

Think of a time when you had two different but similar experiences in a short period. Maybe you attended two holiday parties in the same week or gave two presentations at work.

19 Jan 2024

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

The association between statin therapy and the risks of dementia among patients with heart failure.

19 Jan 2024

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers investigate the need for prioritizing COVID-19 booster vaccination.

19 Jan 2024

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

Electrical deep brain stimulation (DBS) is a well-established method for treating disordered movement in Parkinson's disease.

18 Jan 2024

UNC scientists develop "smart" patch for precision drug delivery

University of North Carolina at Chapel Hill scientists created a new drug delivery system, called the Spatiotemporal On-Demand Patch (SOP), which can receive commands wirelessly from a smartphone or computer to schedule and trigger the release of drugs from individual microneedles.

18 Jan 2024

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

The Aston Research Centre for Health in Ageing (ARCHA) at Aston University has received £400,000 in funding to recruit four PhD students for a dementia research programme.

18 Jan 2024

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Alzheimer's disease, which is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells.

18 Jan 2024

Women and minorities bear the brunt of medical misdiagnosis

Charity Watkins sensed something was deeply wrong when she experienced exhaustion after her daughter was born.

18 Jan 2024

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Approximately 23% of people diagnosed with Alzheimer's disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Jan 2024

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?

New technique helps track the brain's "off switches"

What’s indoor air quality like in long-term care facilities during wildfires? Worse than you’d think.

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Posterior cortical atrophy predicts Alzheimer's, study finds

NHS Health Check linked to lower disease rates and mortality, study shows

Monoclonal antibodies for Alzheimer's offer little benefit, raise safety concerns

Thinning brain tissue predicts dementia up to a decade before symptoms

New study examines trends in liquid laundry detergent packet exposures among young children

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

Unveiling the cellular mechanisms of engram consolidation and memory refinement

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

UNC scientists develop "smart" patch for precision drug delivery

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Women and minorities bear the brunt of medical misdiagnosis

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Aneuro: A Year of Neuroscience in Review eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: A Year of Neuroscience in Review eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in